Yoshinori Kikuchi
Overview
Explore the profile of Yoshinori Kikuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamaguchi K, Kikuchi Y, Kimura Y, Iwasaki S, Takuma K, Okano N, et al.
Oncology
. 2024 Dec;
1-11.
PMID: 39709950
Introduction: Nanoliposomal irinotecan (nal-IRI) + 5-fluorouracil (FU)/leucovorin (LV) is the new standard second-line therapy for advanced pancreatic cancer (PC). Tegafur, gimeracil, and oteracil potassium (S-1) have been used in advanced...
2.
Kikuchi Y, Shimada H, Yamasaki F, Yamashita T, Araki K, Horimoto K, et al.
Int J Clin Oncol
. 2024 Mar;
29(5):512-534.
PMID: 38493447
In recent years, rapid advancement in gene/protein analysis technology has resulted in target molecule identification that may be useful in cancer treatment. Therefore, "Clinical Practice Guidelines for Molecular Tumor Marker,...
3.
Wakabayashi M, Kikuchi Y, Yamaguchi K, Matsuda T
J Egypt Natl Canc Inst
. 2023 Dec;
35(1):40.
PMID: 38093170
Trousseau syndrome is a paraneoplastic syndrome associated with a risk of poor prognosis. We reviewed the survival time and prognosis of patients with Trousseau syndrome. We identified 40 cases from...
4.
Kikuchi Y, Shimada H, Hatanaka Y, Kinoshita I, Ikarashi D, Nakatsura T, et al.
Int J Clin Oncol
. 2023 Nov;
29(1):1-19.
PMID: 38019341
With advances in gene and protein analysis technologies, many target molecules that may be useful in cancer diagnosis have been reported. Therefore, the "Tumor Marker Study Group" was established in...
5.
Kikuchi Y, Yamaguchi K, Shimizu R, Matsumoto Y, Kurose Y, Okano N, et al.
Int Cancer Conf J
. 2023 Aug;
12(4):285-290.
PMID: 37577338
Intrahepatic cholangiocarcinoma is a condition with a poor prognosis. Traditionally, there was no cure unless important drugs such as gemcitabine, cisplatin, and tegafur/gimeracil/uracil potassium showed efficacy. Pemigatinib has recently become...
6.
Yamano S, Takeda T, Goto Y, Hirai S, Furukawa Y, Kikuchi Y, et al.
Respir Res
. 2023 Feb;
24(1):47.
PMID: 36782232
Background: Recently in Japan, six workers at a chemical plant that manufactures resins developed interstitial lung diseases after being involved in loading and packing cross-linked water-soluble acrylic acid polymers (CWAAPs)....
7.
Yamano S, Goto Y, Takeda T, Hirai S, Furukawa Y, Kikuchi Y, et al.
Part Fibre Toxicol
. 2022 Sep;
19(1):58.
PMID: 36100920
Background: Most toxicological studies on titanium dioxide (TiO) particles to date have concentrated on carcinogenicity and acute toxicity, with few studies focusing of pneumoconiosis, which is a variety of airspace...
8.
Yamano S, Takeda T, Goto Y, Hirai S, Furukawa Y, Kikuchi Y, et al.
Sci Rep
. 2022 Sep;
12(1):14969.
PMID: 36056156
With the rapid development of alternative methods based on the spirit of animal welfare, the publications of animal studies evaluating endpoints such as cancer have been extremely reduced. We performed...
9.
Takeda T, Yamano S, Goto Y, Hirai S, Furukawa Y, Kikuchi Y, et al.
Part Fibre Toxicol
. 2022 May;
19(1):35.
PMID: 35562764
No abstract available.
10.
Matsui T, Nagai H, Amanuma M, Kobayashi K, Ogino Y, Mukozu T, et al.
Clin J Gastroenterol
. 2022 Apr;
15(4):796-802.
PMID: 35430638
Left-side portal hypertension (LSPH) is caused by isolated obstruction of the splenic vein and is associated with esophagogastric varices that extend from the lower esophagus to the greater curvature of...